Related references
Note: Only part of the references are listed.A Structural Basis for Inhibition of the Complement Initiator Protease C1r by Lyme Disease Spirochetes
Ryan J. Garrigues et al.
JOURNAL OF IMMUNOLOGY (2021)
Complement mediates binding and procoagulant effects of ultralarge HIT immune complexes
Sanjay Khandelwal et al.
BLOOD (2021)
Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS
Shruti Chaturvedi et al.
BLOOD (2020)
Eculizumab in refractory catastrophic antiphospholipid syndrome: a case report and systematic review of the literature
Maria Giulia Tinti et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2019)
The risk of major bleeding in patients with suspected heparin-induced thrombocytopenia
Allyson M. Pishko et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Heterogeneity in neutrophil responses to immune complexes
Madelaine Duarte et al.
BLOOD ADVANCES (2019)
The Lectin Pathway of Complement in Myocardial ischemia/Reperfusion injury-Review of its Significance and the Potential impact of Therapeutic interference by C1 esterase inhibitor
Anneza Panagiotou et al.
FRONTIERS IN IMMUNOLOGY (2018)
Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia
David J. Kuter et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Borrelia burgdorferi BBK32 Inhibits the Classical Pathway by Blocking Activation of the C1 Complement Complex
Brandon L. Garcia et al.
PLOS PATHOGENS (2016)
Effect of Blood Sampling, Processing, and Storage on the Measurement of Complement Activation Biomarkers
Shangbin Yang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
Catastrophic antiphospholipid syndrome and heparin-induced thrombocytopenia-related diseases or chance association?
Nay T. Tun et al.
BLOOD COAGULATION & FIBRINOLYSIS (2015)
Eculizumab Induces Sustained Remission in a Patient With Refractory Primary Catastrophic Antiphospholipid Syndrome
Thomas A. Zikos et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2015)
Complement system part I - molecular mechanisms of activation and regulation
Nicolas S. Merle et al.
FRONTIERS IN IMMUNOLOGY (2015)
The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions
Y. M. LUCISANO VALIM et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35)
Dong Liu et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2009)
Risk factors for unfavorable clinical outcome in patients with documented heparin-induced thrombocytopenia
Ismail Elalamy et al.
THROMBOSIS RESEARCH (2009)
The alternative complement pathway revisited
Morten Harboe et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis
Nirmal K. Banda et al.
JOURNAL OF IMMUNOLOGY (2006)
Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia
L Rauova et al.
BLOOD (2005)
A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice
JM Thurman et al.
MOLECULAR IMMUNOLOGY (2005)
The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation
M Harboe et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Ischaemia-reperfusion is an event triggered by immune complexes and complement
RK Chan et al.
BRITISH JOURNAL OF SURGERY (2003)
Role for the alternative complement pathway in ischemia/reperfusion injury
GL Stahl et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Arthritis critically dependent on innate immune system players
H Ji et al.
IMMUNITY (2002)
Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcγRIIA
MP Reilly et al.
BLOOD (2001)
Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies
GM Arepally et al.
BLOOD (2000)
Share Paper
